Information Provided By:
Fly News Breaks for March 5, 2020
Mar 5, 2020 | 06:13 EDT
BofA analyst Geoff Meacham downgraded Alexion to Neutral from Buy with a price target of $110, down from $130. The analyst notes that the company has had a good commercial execution for Soliris/Ultomiris with "overblown competitor concerns", but also warns that until 2021/2022, the "complement competitive landscape" will be perceived as a challenge, resulting in a relative sector lag for Alexion shares.
News For ALXN From the Last 2 Days
There are no results for your query ALXN